Compounded semaglutide available through Noom-GLP1 is produced in an FDA-registered facility but has not been reviewed by the FDA for safety, efficacy, or quality
Side Effects & Safety GI side effects (nausea, vomiting, diarrhea) are common, particularly during dose escalation, consistent with GLP-1 agonist class effects
Your provider will guide you on the dosing schedule best suited to your wellness goals
Body Weight Reduction in Women Treated with Tirzepatide by Reproductive Stage: A Post Hoc Analysis from the SURMOUNT Program. Obesity , 12 Mar
& Trenell, M
If you experience symptoms of the following adverse effects, stop taking semaglutide and contact your healthcare provider: Thyroid tumors: Semaglutide may increase the risk for certain types of thyroid tumors including medullary thyroid cancer or multiple endocrine neoplasia syndrome 2 (MEN2)